Drug or chemical-induced diabetes mellitus can lead to proliferative diabetic retinopathy with macular edema, particularly in both eyes. This condition arises from the toxic effects of certain medications or chemicals on insulin production or action, resulting in hyperglycemia and subsequent retinal complications. Accurate coding with ICD-10 Code E09.3513 is essential for proper diagnosis, documentation, medical billing, and public health reporting, ensuring that healthcare providers can effectively manage and treat this serious complication.
ICD-10 Code E09.3513 represents drug or chemical-induced diabetes mellitus with proliferative diabetic retinopathy and macular edema in both eyes. This code should be used when documenting cases where diabetes is a direct result of pharmacological agents, leading to severe ocular complications. It is crucial for accurate clinical documentation and billing, particularly in cases requiring specialized ophthalmological care.
Drug or chemical-induced diabetes mellitus can progress to proliferative diabetic retinopathy with macular edema, necessitating urgent medical intervention. This condition is often caused by medications that impair insulin secretion or action, leading to chronic hyperglycemia and retinal damage. Early detection and management are critical to prevent vision loss.
ICD-10 Code E09.3513 is utilized in SOAP notes to document the presence of drug-induced diabetes with associated ocular complications. It plays a vital role in capturing patient symptoms, assessments, and treatment plans, ensuring comprehensive care in both acute and chronic settings.
In SOAP notes, ICD-10 Code E09.3513 connects subjective patient reports and objective clinical findings to a formal diagnosis of drug-induced diabetes with proliferative retinopathy. This code is essential for ensuring continuity of care, supporting accurate billing, and meeting EHR documentation standards.
Management of Drug/chem diab with prolif diab rtnop with macular edema, bi requires a multifaceted approach, focusing on glycemic control and ocular health.


HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.
Learn moreICD-10 Code E09.3513 is critical in medical billing, particularly in hospital, ER, or specialty care settings for diabetes-related complications.
| CPT Code | Description |
|---|---|
| 99214 | Established patient office visit, moderate complexity. |
| 92014 | Ophthalmologic examination, comprehensive, established patient. |
| 67028 | Laser photocoagulation for diabetic retinopathy. |
| 83036 | Hemoglobin A1c test for diabetes management. |
Common Questions About Using ICD-10 Code E09.3513 for Drug/chem diab with prolif diab rtnop with macular edema, bi
What medications can cause drug-induced diabetes?
Certain medications, including corticosteroids, antipsychotics, and some antihypertensives, can induce diabetes by affecting insulin secretion or action, leading to hyperglycemia.
How is proliferative diabetic retinopathy diagnosed?
Proliferative diabetic retinopathy is diagnosed through comprehensive eye examinations, including fundoscopic exams and retinal imaging, which reveal neovascularization and macular edema.
What are the treatment options for diabetic retinopathy?
Treatment options include laser photocoagulation, anti-VEGF injections, and managing blood glucose levels to prevent progression of retinopathy.
Is hospitalization required for this condition?
Hospitalization may be necessary for severe cases of diabetic retinopathy or when complications arise, such as significant vision loss or uncontrolled diabetes.
Clinical Notes
SOAP notes
DAP notes
AI medical notes